Dong Gun Kim

Chief Executive Officer at Immunomic Therapeutics

DG Kim is President of HLB. Before joining the firm, Mr. Kim spent over 30 years as a specialist in M&A, corporate finance and investment management. He began his career at the law firm of Latham & Watkins, where he spent seven years as a corporate finance and M&A attorney. He then worked for ten years on Wall Street as an M&A investment banker, including as head of telecom M&A for Deutsche Bank in New York, advising on $100 billion of transactions. Mr. Kim moved to Korea in 2005 to head up Eugene Asset Management’s alternative investment operations, raising and managing almost KRW 3 trillion (approximately US$3 billion) of funding in private equity, distressed debt and other alternative investments. In 2012, he joined E-Land Group, a Korean conglomerate operating in fashion and retail, and served as Group CFO for three years. He then spent another three years as CFO and Deputy CIO of Allied Inventors Fund, a specialty private equity fund based in Seattle investing in IP assets with over $600 million under management. Mr. Kim has an A.B. in Physics from Harvard College and a J.D. from Harvard Law School.

Links